Table 3 Perceived barriers regarding the use of CTP
From: Cannabis in medicine: a national educational needs assessment among Canadian physicians
Factor | n 1 | % |
|---|---|---|
Concern that patients who request medical cannabis may actually want it for recreational purposes | 279 | 65 |
Lack of clinical guidelines for the use of cannabis for medical purposes | 271 | 64 |
Risks and benefits are not sufficiently clear for potential therapeutic uses | 237 | 56 |
Lack of personal knowledge/education or information regarding the use of cannabis for medical purposes | 214 | 50 |
Insufficient information regarding the appropriate use of cannabis for medical purposes | 212 | 50 |
Instruction from medical associations, licensing bodies, Royal College, College of Family Physicians or Canadian Medical Protective Association | 201 | 47 |
Potential liability concerns | 194 | 46 |
Concern about possible side effects | 190 | 45 |
Uncertainty about possible interactions with other medications | 167 | 39 |
Belief that cannabis is not an appropriate treatment in a specific case | 141 | 33 |
Requirement to sign a declaration indicating awareness that cannabis is not an approved therapeutic under the Food and Drug Regulations | 138 | 32 |
Uncertainty over whether cannabis has any medicinal value | 117 | 27 |
Availability of prescription cannabinoids (e.g. nabiximols, dronabinol or nabilone) | 98 | 23 |
Other | 66 | 15 |